Voloridge Investment Management
PRCT icon

Voloridge Investment Management’s Procept Biorobotics PRCT Stock Holding History

Voloridge Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-228,364
Closed -$13.3M – 1318
2025
Q1 		$13.3M Sell
228,364
-226,010
-50% -$15.4M 0.05% 476
2024
Q4 		$36.6M Buy
454,374
+171,029
+60% +$14.6M 0.13% 221
2024
Q3 		$22.7M Sell
283,345
-88,716
-24% -$6.3M 0.08% 335
2024
Q2 		$22.7M Buy
372,061
+145,057
+64% +$8.63M 0.08% 319
2024
Q1 		$11.2M Buy
+227,004
New +$10.8M 0.04% 465
2023
Q3 		– Sell
-10,750
Closed -$380K – 1563
2023
Q2 		$380K Sell
10,750
-99,136
-90% -$3.28M ﹤0.01% 1267
2023
Q1 		$3.12M Sell
109,886
-5,604
-5% -$198K 0.02% 832
2022
Q4 		$4.8M Sell
115,490
-28,750
-20% -$1.23M 0.03% 653
2022
Q3 		$5.98M Sell
144,240
-21,991
-13% -$877K 0.03% 590
2022
Q2 		$5.43M Buy
+166,231
New +$6.05M 0.03% 642

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Voloridge Investment Management's PRCT Position: Q2 2025 in Review

Voloridge Investment Management sold out of Procept Biorobotics (PRCT) in Q2 2025, closing a stake of 228,364 shares — an estimated $13.3M sold.

Voloridge Investment Management first reported a position in PRCT in Q2 2022 and held it in 10 quarters. The position peaked at $36.6M in Q4 2024. 271 funds tracked by Wall St. Rank hold PRCT as of Q2 2025.

  • Voloridge Investment Management reported no remaining Procept Biorobotics position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 228,364 Procept Biorobotics shares in Q2 2025, an estimated $13.3M.
  • Voloridge Investment Management first reported a position in Procept Biorobotics in Q2 2022 and held it in 10 quarters.
  • Voloridge Investment Management's Procept Biorobotics position peaked at $36.6M in Q4 2024.
  • 271 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.